Rentech, Inc. (NASDAQ:RTK) announced a new long-term processing agreement between its subsidiaries, Fulghum Fibres Chile (Fulghum), Forestal Pacifico and Forestal Los Andes, and Astillas Exportaciones Limitada (Astex Ltda.), the Chilean subsidiary of Japan’s Mitsubishi Corporation. Rentech, Inc. (NASDAQ:RTK) net profit margin is 4.60% and weekly performance is 4.87%. On last trading day company shares ended up $2.37. Analysts mean target price for the company is $3.11. Rentech, Inc. (NASDAQ:RTK) distance from 50-day simple moving average (SMA50) is 8.60%.
Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced that the United States Food and Drug Administration (FDA) has extended its review of the resubmitted New Drug Application (NDA) for NB32, the Company’s investigational medication being evaluated for weight loss. The new Prescription Drug User Fee Act (PDUFA) action date has been set for September 11, 2014.
Orexigen Therapeutics, Inc. (NASDAQ:OREX) shares advanced 7.52% in last trading session and ended the day on $6.29. OREX return on assets is -63.60%. Orexigen Therapeutics, Inc. (NASDAQ:OREX) quarterly performance is -11.90%.
Rambus Inc. (NASDAQ:RMBS) reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.14. The company had revenue of $78.29 million for the quarter, compared to the consensus estimate of $72.48 million. During the same quarter in the previous year, the company posted ($0.09) earnings per share. The company’s revenue for the quarter was up 17.1% on a year-over-year basis. Analysts expect that Rambus will post $0.29 EPS for the current fiscal year. Rambus Inc. (NASDAQ:RMBS) shares moved up 5.43% in last trading session and was closed at $14.38, while trading in range of $13.64 – $.40. Rambus Inc. (NASDAQ:RMBS) year to date (YTD) performance is 51.85%.
On 12 JUNE Theravance Inc (NASDAQ:THRX) announced the appointment of George B. Abercrombie, Senior Vice President, Corporate Partnerships, Commercial. Mr. Abercrombie will report directly to Rick E Winningham, Chief Executive Officer and be responsible for working closely with Theravance Inc (NASDAQ:THRX) ‘s partners to achieve optimal results from the commercialization of the assets shared by the companies. Theravance Inc (NASDAQ:THRX) ended the last trading day at $27.49. Company weekly volatility is calculated as 5.43% and price to cash ratio as 8.35. Theravance Inc (NASDAQ:THRX) showed a positive weekly performance of 6.92%.
On 4 JUNE Solazyme Inc (NASDAQ:SZYM) said it has opened a renewable oils plant in Brazil with its partner Bunge Limited. The plant includes 625,000 liter fermentation tanks and produces the renewable oil and encapsulated lubricant, Encapso™, products. Solazyme Inc (NASDAQ:SZYM) weekly performance is 13.16%. On last trading day company shares ended up $12.04. Analysts mean target price for the company is $13.13. Solazyme Inc (NASDAQ:SZYM) distance from 50-day simple moving average (SMA50) is 16.32%.